TrialDiabetes care2013

Randomized trial of continuous subcutaneous delivery of exenatide by ITCA 650 versus twice-daily exenatide injections in metformin-treated type 2 diabetes.

Robert R Henry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.